Aurora Cannabis and Vectura Fertin Pharma Launch New CBD Lozenge in Canada

Aurora Cannabis and Vectura Fertin Pharma have partnered to launch a new CBD lozenge in Canada. This marks Vectura Fertin Pharma’s first medical cannabis CBD lozenge in the Canadian market and represents a significant step forward in their collaboration with Aurora. The lozenge, manufactured by Cogent International, a subsidiary of Vectura Fertin Pharma, offers a novel dissolvable format for easy dosing.

Scroll to Top